CAS: 151077-62-2 - N-(2-(3-(trifluoromethyl)diazirin-3-yl)phenyl)-4-maleimidobutyramide

Formule : C₁₆H₁₃F₃N₄O₃

InChI : InChI=1/C16H13F3N4O3/c17-16(18,19)15(21-22-15)10-3-1-4-11(9-10)20-12(24)5-2-8-23-13(25)6-7-14(23)26/h1,3-4,6-7,9H,2,5,8H2,(H,20,24)

Synonymes :

• N-(m-(3-(Trifluoromethyl)-diazirin-3-yl)phenyl)-4-maleimidobutyramide
• Tdpmb
• 1H-Pyrrole-1-butanamide, 2,5-dihydro-2,5-dioxo-N-(3-(3-(trifluoromethyl)-3H-diazirin-3-yl)phenyl)-
• 4-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-{3-[3-(trifluoromethyl)-3H-diaziren-3-yl]phenyl}butanamide

1H-Pyrrole-1-butanamide, 2,5-dihydro-2,5-dioxo-N-[3-[3-(trifluoromethyl)-3H-diazirin-3-yl]phenyl]-

CAS : 151077-62-2

• Formule : C₁₆H₁₃F₃N₄O₃
• Masse moléculaire : 366.2946

2,5-Dihydro-2,5-dioxo-N-[3-[3-(trifluoromethyl)-3H-diazirin-3-yl]phenyl]-1H-pyrrole-1-butanamide

CAS : 151077-62-2

2,5-Dihydro-2,5-dioxo-N-[3-[3-(trifluoromethyl)-3H-diazirin-3-yl]phenyl]-1H-pyrrole-1-butanamide (LZP) is an experimental drug that inhibits the growth of cancer cells. It has …

• Formule : C₁₆H₁₃F₃N₄O₃
• Degré de pureté : Min. 95%
• Masse moléculaire : 366.29 g/mol